Neuropathology of Schizophrenia

Schizophrenia: Third Edition

Volumn , Issue , 2011, Pages 372-392

  Harrison, Paul J ^a   Lewis, David A ^b,c   Kleinman, Joel E ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Connectivity; Cytoarchitecture; Gliosis; Hippocampus; Morphometry; Neuropathology; Prefrontal cortex; Psychosis schizophrenia; Thalamus

Indexed keywords

EID: 84886229036     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444327298.ch18     Document Type: Chapter

References (265)

1. Akbarian, S. & Huang, H. S. (2006) Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Research Reviews 52, 293-304.
2. Akbarian, S., Bunney, W.E., Jr, Potkin, S.G. et al. (1993a) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Archives of General Psychiatry 50, 169-177.
3. Akbarian, S., Viñuela, A., Kim, J.J. et al. (1993b) Distorted distribution of nicotinamide-adenine dinucleotilde phosphate-diaphorase neurons in temporal lose of schizophrenic implies anomalous cortical development. Archives of General Psychiatry 50, 178-187.
4. Akbarian, S., Kim, J.J., Potkin, S.G. et al. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archives of General Psychiatry 52, 258-266.
5. Akil, M. & Lewis, D.A. (1997) The cytoarchitecture of the entorhinal cortex in schizophrenia. American Journal of Psychiatry 154, 1010-1012.
6. Akil, M., Pierri, J.N., Whitehead, R.E. et al. (1999) Lamina-specifi c alteration in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. American Journal of Psychiatry 156, 1580-1589.
7. Altar, C.A., Jurata, L.W., Charles, V. et al. (2005) Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts, Biological Psychiatry 58, 85-96.
8. Altshuler, L.L., Conrad, A., Kovelman, J.A. & Scheibel, A.B. (1987) Hippocampal pyramidal cell orientation in schizophrenia: a controlled neurohistologic study of the Yakovlev collection. Archives of General Psychiatry 44, 1094-1098.
9. Anderson, S.A., Classey, J.D., Cond é, F. et al. (1995) Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 67, 7-22.
10. Arnold, S.E. (1997) The medial temporal lobe in schizophrenia. Journal of Neuropsychiatry and Clinical Neuroscience 9, 460-470.
11. Arnold, S.E. & Trojanowski, J.Q. (1996) Recent advances in defi ning the neuropathology of schizophrenia. Acta Neuropathologica 92, 217-231.
12. Arnold, S.E., Hyman, B.T., Van Hoesen, G.W. & Damasio, A.R. (1991a) Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry 48, 625-632.
13. Arnold, S.E., Lee, V.M.Y., Gur, R.E. & Trojanowski, J.Q. (1991b) Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specifi c subfi elds of the hippocampal formation in schizophrenia. Proceedings of the National Academy of Sciences USA 88, 10850-10854.
14. Arnold, S.E., Franz, B.R., Gur, R.C. et al. (1995) Smaller neuron size in schizophrenia hippocampal subfi elds that mediate cortical-hippocampal interactions. American Journal of Psychiatry 152, 738-748.
15. Arnold, S.E., Franz, B.R., Trojanowski, J.Q. et al. (1996) Glial fi brillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathologica 91, 269-277.
16. Arnold, S.E., Ruscheinsky, D.D. & Han, L.Y. (1997) Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biological Psychiatry 42, 639-647.
17. Arnold, S.E., Trojanowski, J.Q., Gur, R.E. et al. (1998) Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Archives of General Psychiatry 55, 225-232.
18. Baldessarini, R.J., Hegarty, J., Bird, E.D. & Benes, F.M. (1997) Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. American Journal of Psychiatry 154, 861-863.
19. Beasley, C.L. & Reynolds, G.P. (1997) Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophrenia Research 24, 349-355.
20. Beasley, C.L., Zhang, Z.J., Patten, I. & Reynolds, G.P. (2002) Selective defi cits in prefrontal cortical GABAergic neurons in schizophrenia defi ned by the presence of calcium-binding proteins. Biological Psychiatry 52, 708-715.
21. Benes, F.M. (2000) Emerging principles of altered neural circuitry in schizophrenia. Brain Research Reviews 31, 251-269.
22. Benes, F.M., Davidson, J. & Bird, E.D. (1986) Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Archives of General Psychiatry 43, 31-35.
23. Benes, F.M., McSparren, J., Bird, E.D. et al. (1991a) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Archives of General Psychiatry 48, 996-1001.
24. Benes, F.M., Sorensen, I. & Bird, E.D. (1991b) Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophrenia Bulletin 17, 597-608.
25. Benes, F.M., Turtle, M., Khan, Y. & Farol, P. (1994) Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Archives of General Psychiatry 51, 477-484.
26. Benes, F.M., Vincent, S.L., Marie, A. & Khan, Y. (1996) Up-regulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75, 1021-1031.
27. Benes, F.M., Kwok, E.W., Vincent, S.L. & Todtenkopf, M.S. (1998) Reduction of non-pyramidal cells in section CA2 of schizophrenics and manic depressives. Biological Psychiatry 44, 88-97.
28. Bernstein, H.-G., Krell, D., Baumann, B. et al. (1998) Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophrenia Research 33, 125-132.
29. Bertolino, A., Nawroz, S., Mattay, V.S. et al. (1996) Regionally specifi c pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. American Journal of Psychiatry 153, 1554-1563.
30. Bertolino, A., Callicott, J.H., Elman, I. et al. (1998) Regionally specifi c neural pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biological Psychiatry 43, 641-648.
31. Bertolino, A., Esposito, G., Callicott, J.H. et al. (2000) Specifi c relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. American Journal of Psychiatry 157, 26-33.
32. Bird, E., Barnes, J., Iversen, L. et al. (1977) Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. The Lancet 310, 1157-1159.
33. Black, J.E., Kodish, I.M., Grossman, A.W. et al. (2004). Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. American Journal of Psychiatry 161, 742-744.
34. Bloom, F.E. (1993) Advancing a neurodevelopmental origin for schizophrenia, Archives of General Psychiatry 50, 224-227.
35. Bogerts, B., Hantsch, J. & Herzer, M. (1983) A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biological Psychiatry 18, 951-969.
36. Bogerts, B., Falkai, P., Haupts, M. et al. (1990) Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophrenia Research 3, 295-301.
37. Bourgeois, J.-P., Goldman-Rakic, P.S. & Rakic, P. (1994) Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cerebral Cortex 4, 78-96.
38. Boyer, P., Phillips, J.L., Rousseau, F.L. & Ilivitsky, S. (2007) Hippocampal abnormalities and memory defi cits: New evidence of a strong pathophysiological link in schizophrenia. Brain Research Reviews 54, 92-112.
39. Bozikas, V.P., K ö vari, E., Bouras, C. & Karavatos, A. (2002) Neurofi brillary tangles in elderly patients with late onset schizophrenia. Neuroscience Letters 324, 109-112.
40. Bravin, M., Morando, L., Vercelli, A. Rossi, F. & Strata, P. (1999) Control of spine formation by electrical activity in the adult rat cerebellum. Proceedings of the National Academy of Sciences USA 96, 1704-1709.
41. Broadbelt, K., Byne, W. & Jones, L.B. (2002). Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophrenia Research 58, 75-81.
42. Bruton, C.J., Crow, T.J., Frith, C. et al. (1990) Schizophrenia and the brain: a prospective cliniconeuropathological study. Psychological Medicine 20, 285-304.
43. Buchsbaum, M.S., Someya, T., Teng, C.Y. et al. (1996) PET and MRI of the thalamus in never-medicated patients with schizophrenia. American Journal of Psychiatry 153, 191-199.
44. Byne, W., Buchsbaum, M.S., Kemether, E. et al. (2001) Magnetic resonance imaging of the thalamic mediodorsal nucles and pulvinar in schizophrenia and schizotypal personality disorder. Archives of General Psychiatry 58, 133-140.
45. Byne, W., Buchsbaum, M.S., Mattiace, L.A. et al. (2002) Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. American Journal of Psychiatry 159, 59-65.
46. Byne, W., Fernandes, J., Haroutunian, V. et al. (2007) Reduction of right medial pulvinar volume and neuron number in schizophrenia. Schizophrenia Research 90, 71-75.
47. Byne, W., Hazlett, E.A., Buchsbaum, M.S., & Kemether, E. (2009) The thalamus and schizophrenia: current status of research. Acta Neuropathologica 117, 347-368.
48. Callicott, J.H., Straub, R.E., Pezawas, L et al. (2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences USA 102, 8627-8632.
49. Carter, C.J. (2006) Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophrenia Research 86, 1-14.
50. Casanova, M.F., Stevens, J.R., Brown, R., Royston, C. & Bruton, C. (2002) Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathologica 103, 313-320.
51. Christison, G.W., Casanova, M.F., Weinberger, D.R. et al. (1989) A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Archives of General Psychiatry 46, 1027-1032.
52. Condé, F., Lund, J.S. Jacobowitz, D.M. et al. (1994) Local circuit neurons immunoreactive for calretinin, calbindin D-28k, or parvalbumin in monkey prefrontal cortex: Distribution and morphology. Journal of Comparative Neurology 341, 95-116.
53. Conrad, A.J., Abebe, T., Austin, R. et al. (1991) Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of General Psychiatry 48, 413-417.
54. Corsellis, J.A.N. (1962) Mental illness and the ageing brain. Institute of Psychiatry Maudsley Monographs No. 9. London: Oxford University Press.
55. Cotter, D., Landau, S., Beasley, C. et al. (2002) The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biological Psychiatry 51, 377-386.
56. Cotter, D., MacKay, D. Frangou, S. et al. (2004) Cell density and cortical thickness in Heschl's gyrus in schizophrenia, major depression and bipolar disorder. British Journal of Psychiatry 185, 258-259.
57. Crow, T.J. (1990) Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophrenia Bulletin 16, 433-443.
58. Crow, T.J. (2004) Cerebral asymmetry and the lateralization of language: core defi cits in schizophrenia as pointers to the gene. Current Opinion in Psychiatry 17, 97-106.
59. Crow, T.J., Ball, J., Bloom, S. et al. (1989) Schizophrenia as an anomaly of development of cerebral asymmetry. Archives of General Psychiatry 46, 1145-1150.
60. Cullen, T.J., Walker, M.A., Parkinson, N. et al. (2003) A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophrenia Research 60, 157-166.
61. Cullen, T.J., Walker, M.A., Eastwood, S.L. et al. (2006) Anomalies of asymmetry of pyramidal cell density and structure in dorsolateral prefrontal cortex in schizophrenia. British Journal of Psychiatry 188, 26-31.
62. Da Cunha, A., Jeffereson, J.J., Tyor, W.R. et al. (1993) Gliosis in human brain: relationship to size but not other properties of astrocytes. Brain Research 600, 161-165.
63. Danos, P., Baumann, B., Kr ä mer, A. et al. (2003) Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophrenia Research 60, 141-155.
64. David, G.B. (1957) The pathological anatomy of the schizophrenias. In: Richter, D., ed. Schizophrenia: Somatic Aspects. Oxford: Pergamon, pp. 93-130.
65. Davidsson, P., Gottfries, J., Bogdanovic, N. et al. (1999) The synaptic-vesicle-specifi c proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophrenia Research 40, 23-29.
66. Davis, K.L., Stewart, D.G., Friedman, J.I. et al. (2003) White matter changes in schizophrenia-Evidence for myelin-related dysfunction. Archives of General Psychiatry 60, 443-456.
67. Daviss, S.R. & Lewis, D.A. (1995) Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Research 59, 81-96.
68. Deicken, R.F., Zhou, L., Corwin, F. et al. (1997) Decreased left frontal lobe N-acetylaspartate in schizophrenia. American Journal of Psychiatry 154, 688-690.
69. DeLisi, L.E. (2008) The concept of progressive brain change in schizophrenia: Implications for understanding schizophrenia. Schizophrenia Bulletin 34, 312-321.
70. Dorph-Petersen, K.-A., Lewis, D.A. (2010) Stereological approaches to identifying neuropathology in psychosis. Biological Psychiatry doi:10.1016/j.biopsych.2010.10.04.30.
71. Dorph-Petersen, K.-A. Pierri, J.N. Sun, Z. et al. (2004) Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types. Journal of Comparative Neurology 472, 449-462.
72. Dorph-Petersen, K.-A. Pierri, J.N. Perel, J.M. et al. (2005) The infl uence of chronic exposure to antipsychotic medications on brain size before and after tissue fi xation: A comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacolgy 30, 1649-1661.
73. Dorph-Petersen, K.A. Pierri, J.N. Wu, Q. et al. (2007) Primary visual cortex volume and total neuron number are reduced in schizophrenia. Journal of Comparative Neurology 501, 290-301.
74. Dracheva, S., Davis, K.L., Chin, B. et al. (2006) Myelin-associated mRNA and protein expression defi cits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease 21, 531-540.
75. Eastwood, S.L. & Harrison, P.J. (1995) Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 69, 339-343.
76. Eastwood, S.L. & Harrison, P.J. (1998) Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience 86, 437-448.
77. Eastwood, S.L. & Harrison, P.J. (1999) Detection and quantifi cation of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fi xed paraffi n wax-embedded sections. Neuroscience 93, 99-106.
78. Eastwood, S.L. & Harrison, P.J. (2000) Hippocampal synaptic pathol-ogy in schizophrenia bipolar disorder and major depression: a study of complexin mRNAs. Molecular Psychiatry 5, 425-432.
79. Eastwood, S.L. & Harrison, P.J. (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders: an immunoblotting study of synaptophysin, gap-43 and the complexins and a review. Brain Research Bulletin 55, 569-578.
80. Eastwood, S.L. & Harrison, P.J. (2003) Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Molecular Psychiatry 8, 821-831.
81. Eastwood, S.L. & Harrison, P.J. (2010) Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biological Psychiatry 67, 1010-1016.
82. Eastwood, S.L. Cairns, N.J. & Harrison, P.J. (2000) Synaptophysin gene expression in schizophrenia: investigation of synaptic pathology in the cerebral cortex. British Journal of Psychiatry 176, 236-242.
83. Eastwood, S.L. Law, A.J. Everall, I.P. & Harrison, P.J. (2003) The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Molecular Psychiatry 8, 148-155.
84. Eastwood, S.L., Walker, M., Hyde, T.M., Kleinman, J.E. & Harrison, P.J. (2010) The DISC1 Ser704Cys substitution affects centrosomal localisation of its binding partner PCM1 in glia in human brain. Human Molecular Genetics 19, 2487-2496.
85. Erickson, S.L. & Lewis, D.A. (2002) Postnatal development of parvalbumin-and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. Journal of Comparative Neurology 448, 186-202.
86. Erickson, S.L. & Lewis, D.A. (2004). Cortical connections of the lateral mediodorsal thalamus in cynomolgus monkeys. Journal of Comparative Neurology 473, 107-127.
87. Esiri, M.M. & Pearson, R.C.A. (2000) Perspectives from other diseases and lesions. In: Harrison, P.J. & Roberts, G.W., eds. The Neuropathology of Schizophrenia: Progress and Interpretation (eds), Oxford: Oxford University Press, pp. 257-276.
88. Ettinger, U., Chitnis, X.A., Kumari, V. et al. (2001) Magnetic resonance imaging of the thalamus in fi rst-episode psychosis. American Journal of Psychiatry 158, 116-118.
89. Ettinger, U., Picchioni, M., Landau, S. et al. (2007) Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia. Archives of General Psychiatry 64, 401-409.
90. Falkai, P. & Bogerts, B. (1986) Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatry and Neurological Science 236, 154-161.
91. Falkai, P., Honer, W.G., David, S. et al. (1999) No evidence for astrogliosis in brains of schizophrenic patients: a post-mortem study. Neuropathology and Applied Neurobiology 25, 48-53.
92. Falkai, P., Schneider-Axmann, T. & Honer, W.G. (2000) Entorhinal cortex pre-alpha cell cluster in schizophrenia: quantitative evidence of a developmental abnormality. Biological Psychiatry 47, 937-943.
93. Fannon, D., Simmons, A., Tennakoon, L. et al. (2003) Selective defi cit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biological Psychiatry 54, 587-598.
94. Friede, R.J. (1989) Developmental Neuropathology. Berlin: Springer Verlag.
95. Friston, K.J. (1998) The disconnection hypothesis. Schizophrenia Research 30, 115-125.
96. Gabriel, S.M., Haroutunian, V., Powchik, P. et al. (1997) Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Archives of General Psychiatry 54, 559-566.
97. Garey, L.J., Ong, W.Y., Patel, T.S. et al. (1998) Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. Journal of Neurology, Neurosurgery and Psychiatry 65, 446-453.
98. Giguere, M. & Goldman-Rakic, P.S. (1988) Mediodorsal nucleus: Areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. Journal of Comparative Neurology 277, 195-213.
99. Gilbert, A.R., Rosenberg, D.R., Harenski, K. et al. (2001) Thalamic volumes in patients with fi rst-episode schizophrenia. American Journal of Psychiatry 158, 618-624.
100. Glantz, L.A. & Lewis, D.A. (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia: regional and diagnostic specifi city. Archives of General Psychiatry 54, 943-952.
101. Glantz, L.A. & Lewis, D.A. (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry 57, 65-73.
102. Glantz, L.A., Austin, M.C. & Lewis, D.A. (2000) Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 48, 389-397.
103. Grieve, K.L., Acu ñ a, C. & Cudeiro, J. (2000) The primate pulvinar nuclei: vision and action. Trends in Neurosciences 23, 35-39.
104. Guidotti, A., Auta, J., Davis, J.M. et al. (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. Archives of General Psychiatry 57, 1061-1069.
105. Guillery, R. (2002) On counting and counting errors. Journal of Comparative Neurology 447, 1-7.
106. Hakak, Y., Walker, J.R., Li, C. et al. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences USA 98, 4746-4751.
107. Hanada, S., Mita, T., Nishino, N. & Tanaka, C. (1987) [3H] Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sciences 40, 239-266.
108. Harrison, P.J. (1999a) The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 122, 593-624.
109. Harrison, P.J. (1999b) The neuropathological effects of antipsychotic drugs. Schizophrenia Research 40, 87-99.
110. Harrison, P.J. (2002) The neuropathology of primary mood disorder. Brain 125, 1428-1449.
111. Harrison, P.J. (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its path ophysiological implications. Psychopharmacology 174, 151- 162.
112. Harrison, P.J. (2007) Schizophrenia susceptibility genes and neurodevelopment, Biological Psychiatry 61, 1119-1120.
113. Harrison, P.J. & Eastwood, S.L. (1998) Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet 352, 1669-1673.
114. Harrison, P.J. & Eastwood, S.L. (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11, 508-519.
115. Harrison, P.J. & Roberts, G.W. (2000) The Neuropathology of Schizophrenia: Progress and Interpretation. Oxford: Oxford University Press.
116. Harrison, P.J. & Weinberger, D.R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10, 40-68.
117. Harrison, P.J. & West, V.A. (2006) Six degrees of separation: on the prior probability that schizophrenia susceptibility genes converge on synapses, glutamate and NMDA receptors, Mol ecular Psychiatry, 11, 981-983.
118. Harrison, P.J., Freemantle, N. & Geddes, J.R. (2003) Meta-analysis of brain weight in schizophrenia. Schizophrenia Research 64, 25-34.
119. Hashimoto, T., Volk, D.W., Eggan, S.M. et al. (2003) Gene expression defi cits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. Journal of Neuroscience 23, 6315-6326.
120. Hashimoto, T., Bergen, S.E., Nguyen, Q.L. et al. (2005) Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. Journal of Neuroscience 25, 372-383.
121. Hashimoto, T., Arion, D., Unger, T. et al. (2008) Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Molecular Psychiatry 13, 147-161.
122. Hayes, T.L. & Lewis, D.A. (1996) Magnopyramidal neurons in the anterior motor speech region: dendritic features and interhemispheric comparisons. Archives of Neurology 53, 1277-1283.
123. Heckers, S. (2001) Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 11, 520-528.
124. Heckers, S., Heinsen, H., Geiger, B. & Beckmann, H. (1991) Hippocampal neuron number in schizophrenia: a stereological study. Archives of General Psychiatry 48, 1002-1008.
125. Heinsen, H., Gössmann, E., R ü b, U. et al. (1996) Variability in the human entorhinal region may confound neuropsychiatric diagnoses. Acta Anatomica 157, 226-237.
126. Highley, J.R., Walker, M.A., Crow, T.J. et al. (2003a) Low medial and lateral right pulvinar volumes in schizophrenia: a postmortem study. American Journal of Psychiatry 160, 1177-1179.
127. Highley, J.R., Walker, M.A., McDonald, B. et al. (2003b) Size of hippocampal pyramidal neurons in schizophrenia. British Journal of Psychiatry 183, 414-417.
128. Hof, P.R. Ungerleider, L.G. Webster, M.J. et al. (1996) Neurofi lament protein in differentially distributed in subpopulations of corticocortical projection neurons in the macaque monkey visual pathways. Journal of Comparative Neurology 376, 112-127.
129. Hof, P.R. Haroutunian, V. Friedrich, V.L. Jr. et al. (2003) Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia, Biological Psychiatry 53, 1075-1085.
130. Holinger, D. Galaburda, A.M. & Harrison, P.J. (2000) Cerebral asymmetry. In: Harrison, P.J. & Roberts, G.W., eds. The Neuropathology of Schizophrenia: Progress and Interpretation. Oxford: Oxford University Press, pp. 151-171.
131. Honer, W.G., Falkai, P., Chen, C. et al. (1999) Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience 91, 1247-1255.
132. Honer, W.G. Young, C. & Falkai, P. (2000) Synaptic pathology. In: Harrison, P.J. & Roberts, G.W., eds. The Neuropathology of Schizophrenia: Progress and Interpretation. Oxford: Oxford University Press, pp. 105-136.
133. Huttenlocher, P.R. (1979) Synaptic density in human frontal cortex: developmental changes and effects of aging. Brain Research 163, 195-205.
134. Irwin, S.A., Galvez, R. & Greenough, W.T. (2000) Dendritic spine structural anomalies in fragile X mental retardation syndrome. Cerebral Cortex 10, 1038-1044.
135. Jakob, H. & Beckmann, H. (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transactions 65, 303-326.
136. Jellinger, K.A. (2009) Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathologica 117, 423-427.
137. Jellinger, K.A. & Gabriel, E. (1999) No increased incidence of Alzheimer's disease in elderly schizophrenics. Acta Neuropathologica 97, 165-169.
138. Jeste, D.V. & Lohr, J.B. (1989) Hippocampal pathologic fi ndings in schizophrenia: a morphometric study. Archives of General Psychiatry 46, 1019-1024.
139. Kalman, M., Csillag, A., Schleicher, A. et al. (1993) Long-term effects of anterograde degeneration on astroglial reaction in the rat geniculo-cortico system as revealed by computerized image analysis. Anatomical Embryology 187, 1-7.
140. Kalus, P., Muller, T.J., Zuschratter, W. & Senitz, D. (2000) The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 11, 3621-3625.
141. Karoutzou, G., Emrich, H.M. & Dietrich, D.E. (2008) The myelin-pathogenesis puzzle in schizophrenia: a literature review. Molecular Psychiatry 13, 245-260.
142. Karson, C.N., Mrak, R.E., Schluterman, K.O. et al. (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophenia: a possible neurochemical basis for ' hypofrontality '. Molecular Psychiatry 4, 39-45.
143. Katsel, P., Davis, K.L. & Haroutunian, V. (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study. Schizophrenia Research 79, 157-173.
144. Kaufmann, W.E. & Moser, H.W. (2000) Dendritic anomalies in disorders associated with mental retardation. Cerebral Cortex 10, 981-991.
145. Kemether, E.M., Buchsbaum, M.S., Byne, W. et al. (2003) Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Archives of General Psychiatry 60, 983-991.
146. Kemper, T.L. & Bauman, M. (1998) Neuropathology of infantile autism. Journal of Neuropathology and Experimental Neurology 57, 645-652.
147. Kim, S. & Webster, M.J. (2010) Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Molecular Psychiatry [Epub ahead of print].
148. Kleinman, J.E., Law, A.J., Lipska, B.K. et al. (2011) Genetic neuropathology of schizophrenia: new approaches to an old question, and new uses for post mortem human brains. Biological Psychiatry (in press).
149. Kolluri, N., Sun, Z., Sampson, A.R. & Lewis, D.A. (2005) Lamina-specifi c reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. American Journal of Psychiatry 162, 1200-1202.
150. Kolomeets, N.S. Orlovskaya, D.D. Rachmanova, V.I. & Uranova, N.A. (2005) Ultrastructural alterations in hippocampal mossy fi ber synapses in schizophrenia: A postmortem morphometric study. Synapse 57, 47-55.
151. Kolomeets, N.S., Orlovskaya, D.D. & Uranova, N.A. (2007) Decreased numerical density of CA3 hippocampal mossy fi ber synapses in schizophrenia. Synapse 61, 615-621.
152. Konick, L.C. & Friedman, L. (2001) Meta-analysis of thalamic size in schizophrenia. Biological Psychiatry 49, 28-38.
153. Konopaske, G.T., Dorph-Petersen, K.A., Pierri, J.N. et al. (2007). Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32, 1216-1223.
154. Konrad, A. & Winterer, G. (2008) Disturbed structural connectivity in schizophrenia-Primary factor in pathology or epiphenomenon? Schizophrenia Bulletin 34, 72-92.
155. Kovalenko, S., Bergmann, A., Schneider-Axmann, T. et al. (2003) Regio entorhinalis in schizophrenia: More evidence for migrational disturbances and suggestions for a new biological hypothesis. Pharmacopsychiatry 36 (Suppl. 3), S158-S161.
156. Kovelman, J.A. & Scheibel, A.B. (1984) A neurohistological correlate of schizophrenia. Biological Psychiatry 19, 1601-1621.
157. Kreczmanski, P., Heinsen, H., Mantua, V. et al. (2007) Volume, neuron density and total neuron number in fi ve subcortical regions in schizophrenia. Brain 130, 678-692.
158. Krimer, L.S., Herman, M.M., Saunders, R.C. et al. (1997) A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cerebral Cortex 7, 732-739.
159. Lambe, E.K., Krimer, L.S. & Goldman-Rakic, P.S. (2000) Differential postnatal development of catecholamine and serotonin inputs to identifi ed neurons in prefrontal cortex of rhesus monkey. Journal of Neuroscience 20, 8780-8787.
160. Law, A.J. & Harrison, P.J. (2003) The distribution and morphology of prefrontal cortex pyramidal neurons identifi ed using anti-neurofi lament antibodies SMI32, N200 and FNP7.
161. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. Journal of Psychiatric Research 37, 487-499.
162. Law, A.J., Weickert, C.S., Hyde, T.M. et al. (2004) Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: Molecular evidence for a pathology of dendritic spines, American Journal of Psychiatry 161, 1848-1855.
163. Law, A.J., Lipska, B.K., Weickert, C.S. et al. (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proceedings of the National Academy of Sciences of the United States of America 103, 6747-6752.
164. Leong, S.L., Cappai, R., Barnham, K.J. & Pham, C.L. (2009) Modulation of alpha-synuclein aggregation by dopamine: a review. Neurochemical Research 34, 1838-1846.
165. Lesch, A. & Bogerts, B. (1984) The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter. European Archives of Psychiatry & Neurological Sciences 234, 212-219.
166. Levitt, J.B. Lewis, D.A. Yoshioka, T. & Lund, J.S. (1993) Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (areas 9 and 46). Journal of Comparative Neurology 338, 360-376.
167. Lewis, D.A. (1997) Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16, 385-398.
168. Lewis, D.A. (2000) Distributed disturbances in brain structure and function in schizophrenia. American Journal of Psychiatry 157, 1-2.
169. Lewis, D.A. & Levitt, P. (2002) Schizophrenia as a disorder of neurodevelopment, Annual Review of Neuroscience 25, 409-432.
170. Lewis, D.A. & Sesack, S.R. (1997) Dopamine systems in the primate brain. In: Bloom, F.E., Bj ö rklund, A. & H ö kfelt, T., eds. Handbook of Chemical Neuroanatomy. Amsterdam: Elsevier Science, pp. 261-373.
171. Lewis, D.A. & Lieberman, J.A. (2000) Catching up on schizophrenia: Natural history and neurobiology. Neuron 28, 325-334.
172. Lewis, D.A. & Gonzales-Burgos, G. (2008) Neuroplasticity and neocortical circuits in schizophrenia. Neuropsychopharmacology 33, 141-165.
173. Lewis, D.A., Cruz, D.A., Melchitzky, D.S. & Pierri, J.N. (2001) Lamina-specifi c defi cits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: Evidence for fewer projections from the thalamus. American Journal of Psychiatry 158, 1411-1422.
174. Lieberman, J.A. (1999) Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biological Psychiatry 46, 729-739.
175. Maldonado-Aviles, J.G., Wu, Q., Sampson, A.R. & Lewis, D. A. (2006). Somal size of immunolabeled pyramidal cells in the prefrontal cortex of subjects with schizophrenia. Biological Psychiatry 60, 226-234.
176. Marti, E., Ferrer, I., Ballabriga, J. & Blasi, J. (1998) Increase in SNAP-25 immunoreactivity in mossy fi bers following transient forebrain ischemia in the gerbil. Acta Neuropathologica 95, 254-260.
177. Masliah, E., Mallory, M. Hansen, L. et al. (1993) Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 43, 192-197.
178. Maurer, I., Zierz, S. & Moller, H. (2001). Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophrenia Research 48, 125-136.
179. McDonald, B., Highley, J.R., Walker, M.A. et al. (2000) Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. American Journal of Psychiatry 157, 40-47.
180. McIntosh, A.M., Moorhead, T.W., Job, D. et al. (2008) The effects of a neuregulin 1 variant on white matter density and integrity. Molecular Psychiatry 13, 1054-1059.
181. Melchitzky, D.S., Sesack, S.R. & Lewis, D.A. (1999) Parvalbumin-immunoreactive axon terminals in macaque monkey and human prefrontal cortex: Laminar, regional and target specifi-city of Type I and Type II synapses. Journal of Comparative Neurology 408, 11-22.
182. Middleton, F.A., Mirnics, K., Pierri, J.N. et al. (2002) Gene expression profi ling reveals alterations of specifi c metabolic pathways in schizophrenia. Journal of Neuroscience 22, 2718-2729.
183. Mirnics, K., Middleton, F.A., Marquez, A. et al. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67.
184. Mitkus, S.N., Hyde, T.M., Vakkalanka, R. et al. (2008) Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophrenia Research 98, 129-138.
185. Morris, H.M., Hashimoto, T. & Lewis, D.A. (2008) Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cerebral Cortex 18, 1575-1587.
186. Mulcrone, J., Whatley, S.A., Ferrier, I.N. & Marchbanks, R.M. (1995) A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening. Schizophrenia Research 14, 203-213.
187. Murphy, G.M., Jr, Lim, K.O., Wieneke, M. et al. (1998) No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biological Psychiatry 43, 205-209.
188. Nave, K.-A. & Trapp, B.D. (2008) Axon-glial signaling and the glial support of axon function. Annual Review of Neuroscience 31, 535-561.
189. Nelson, M.D., Saykin, A.J., Flashman, L.A. & Riordan, H.J. (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Archives of General Psychiatry 55, 433-440.
190. Niizato, K., Arai, T., Kuroki, N., Kase, K., Iritani, S. & Ikeda, K. (1998) Autopsy study of Alzheimer's disease brain pathology in schizophrenia, Schizophrenia Research, 31, pp. 177-184.
191. Ohnuma, T., Augood, S.J., Arai, H. et al. (1999). Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: Focus on GABA content, GABAA receptor a-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience 93, 441-448.
192. Pakkenberg, B. (1990) Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Archives of General Psychiatry 47, 1023-1028.
193. Pakkenberg, B. (1993) Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biological Psychiatry 34, 768-772.
194. Pantazopoulos, H., Woo, T.-U.W., Lim, M.P., Lange, N. & Berretta, S. (2010) Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Archives of General Psychiatry 67, 155-166.
195. Perez-Costas, E, Melendez-Ferro, M., & Roberts, R.C. (2010) Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. Journal of Neurochemistry 113, 287-302.
196. Perrone-Bizzozero, N.I., Sower, A.C., Bird, E.D. et al. (1996) Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proceedings of the National Academy of Sciences 93, 14182-14187.
197. Pierce, J.P. & Lewin, G.R. (1994) An ultrastructural size principle. Neuroscience 58, 441-446.
198. Pierri, J.N., Melchitzky, D.S. & Lewis, D.A. (1999) Volume and neuronal number of the primate mediodorsal thalamic nucleus: effects of chronic haloperidol administration. Society for Neuroscience Abstracts 25, 1833.
199. Pierri, J.N., Volk, C.L.E., Auh, S. et al. (2001). Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Archives of General Psychiatry 58, 466-473.
200. Pierri, J.N., Volk, C.L., Auh, S. et al. (2003). Somal size of prefrontal cortical pyramidal neurons in schizophrenia: Differential effects across neuronal subpopulations. Biological Psychiatry 54, 111-120.
201. Plum, F. (1972) Prospects for research on schizophrenia. Neuropathological fi ndings. Neuroscience Research Program Bulletin 10, 384-388.
202. Popken, G.J., Bunney, W.E., Jr., Potkin, S.G. & Jones, E.G. (2000) Subnucleus-specifi c loss of neurons in medial thalamus of schizophrenics. Proceedings of the National Academy of Sciences USA 97, 9276-9280.
203. Portas, C.M., Goldstein, J.M., Shenton, M.E. et al. (1998) Volume tric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biological Psychiatry 43, 649-659.
204. Prabakaran, S., Swatton, J.E., Ryan, M.M. et al. (2004) Mitochondrial dysfunction in Schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry 9, 684-697.
205. Prasad, K.M.R., Chowdari, K.V., Nimgaonkar, V.L. et al. (2005) Genetic polymorphisms of the RGS4 and dorsolateral prefrontal coretx morphometry among fi rst episode schizophrenia patients., Molecular Psychiatry 10, 213-219.
206. Prince, J.A., Blennow, K., Gottfries, C.G. et al. (1999) Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21, 372-379.
207. Prohovnik, I., Dwork, A.J., Kaufman, M.A. & Wilson, N. (1993) Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophrenia Bulletin 19, 805-816.
208. Pucak, M.L., Levitt, J.B., Lund, J.S. & Lewis, D.A. (1996) Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. Journal of Comparative Neurology 376, 614-630.
209. Purohit, D.P., Peri, D.P., Haroutunian, V. et al. (1998) Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a portmortem neuropathologic study of 100 cases. Archives of General Psychiatry 55, 205-211.
210. Rajkowska, G., Selemon, L.D. & Goldman-Rakic, P.S. (1998) Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Archives of General Psychiatry 55, 215-224.
211. Rapp, M.A., Schnaider-Beeri, M., Purohit, D.P. et al. (2010) Cortical neuritic plaques and neurofi brillary tangles are related to dementia severity in elderly schizophrenia patients. Schizophrenia Research 116, 90-96.
212. Riederer, P., Gsell, W., Calza, L. et al. (1995) Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research. Report from the European Dementia and Schizophrenia Network (BIOMED 1). Journal of Neural Transmission 102, 255-264.
213. Roberts, G.W. & Harrison, P.J. (2000) Gliosis and its implications for the disease process. In: Harrison, P.J. & Roberts, G.W., eds. The Neuropathology of Schizophrenia: Progress and Interpretation. Oxford: Oxford University Press, pp. 137-150.
214. Roberts, R.C., Roche, J.K., & Conley, R.R. (2005) Synaptic differences in the postmortem striatum of subjects with schizophrenia: A stereological ultrastructural analysis. Synapse 56, 185-197.
215. Rosoklija, G., Toomayan, G., Ellis, S.P. et al. (2000) Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary fi ndings. Archives of General Psychiatry 57, 349-356.
216. Sawada, K., Barr, A.M., Nakamura, M. et al. (2005) Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Archives of General Psychiatry 62, 263-272.
217. Scherk, H. & Falkai, P. (2006) Effects of antipsychotics on brain structure. Current Opinion in Psychiatry 19, 145-150.
218. Schmitt, A., Steyskal, C., Bernstein, H.G., et al. (2009) Stereologic investigation of the posterior part of the hippocampus in schizophrenia. Acta Neuropathologica 117, 395-407.
219. Schmitz, C. & Rezaie, P. (2008) The neuropathology of autism: where do we stand? Neuropathology and Applied Neurobiology 34, 4-11.
220. Selemon, L.D. & Goldman-Rakic, P.S. (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biological Psychiatry 45, 17-25.
221. Selemon, L.D. Rajkowska, G. & Goldman-Rakic, P.S. (1995) Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Archives of General Psychiatry 52, 805-818.
222. Selemon, L.D., Rajkowska, G. & Goldman-Rakic, P.S. (1998) Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. Journal of Comparative Neurology 392, 402-412.
223. Selemon, L.D., Lidow, M.S. & Goldman-Rakic, P.S. (1999) Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biological Psychiatry 46, 161-172.
224. Shao, L. & Vawter, M.P. (2008) Shared gene expression alterations in schizophrenia and bipolar disorder. Biological Psychiatry 64, 89-97.
225. Shapiro, R.M. (1993) Regional neuropathology in schizophrenia: Where are we? Where are we going, Schizophrenia Research 10, 187-239.
226. Simpson, M.D.C., Slater, P., Deakin, J.F.W. et al. (1989) Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neuroscience Letters 107, 211-215.
227. Smiley, J.F., Rosoklija, G., Mancevski, B., Mann, J.J., Dwork, A.J., & Javitt, D.C. (2009) Altered volume and hemispheric asymmetry of the superfi cial cortical layers in the schizophrenia planum temporal. European Journal of Neuroscience 30, 449-463.
228. Sommer, I., Aleman, A., Ramsey, N. et al. (2001) Handedness, language lateralisation and anatomical asymmetry in schizophrenia - Meta-analysis. British Journal of Psychiatry 178, 344-351.
229. Stanley, J.A., Williamson, P.C., Drost, D.J. et al. (1996) An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophrenia Bulletin 22, 597-609.
230. Stephan, K.E., Baldeweg, T. & Friston, K.J. (2006) Synaptic plasticity and dysconnection in schizophrenia. Biological Psychiatry 59, 929-939.
231. Stevens, J.R. (1982) Neuropathology of schizophrenia. Archives of General Psychiatry 39, 1131-1139.
232. Stevens, J.R., Casanova, M.F., Poltorak, M. & Buchan, G.C. (1992) Comparison of immunocytochemical and Holzer's methods for detection of acute and chronic glioses in human post-mortem material. Journal of Neuropsychiatry and Clinical Neuroscience 4, 168-173.
233. Straub, R.E., Lipska, B.K., Egan, M.F. et al. (2007) Allelic variation in GAD1 (GAD67) is associated with schizophrenia and infl uences cortical function and gene expression. Molecular Psychiatry 12, 854-869.
234. Suddath, R.L., Christison, G.W., Torrey, E.F. et al. (1990) Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine 322, 789-794.
235. Sugino, K., Hempel, C.M., Miller, M.N. et al. (2006). Molecular taxonomy of major neuronal classes in the adult mouse forebrain. Nature Neuroscience 9, 99-107.
236. Sweet, R.A., Pierri, J.N., Auh, S. et al. (2003). Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology 28, 599-609.
237. Sweet, R.A., Bergen, S.E., Sun, Z. et al. (2004). Pyramidal cell size reduction in schizophrenia: Evidence for involvement of auditory feedforward circuits. Biological Psychiatry 55, 1128-1137.
238. Sweet, R.A., Bergen, S.E., Sun, Z. et al. (2007). Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biological Psychiatry 61, 854-864.
239. Talbot, K., Eidem, W.L., Tinsley, C.L. et al. (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. Journal of Clinical Investigation 113, 1353-1363.
240. Tamminga, C.A., Stan, A.D. & Wagner, A.D. (2010) The hippocampal formation in schizophrenia. American Journal of Psychiatry (Epub ahead of print).
241. Thompson, P.M., Sower, A.C. & Perrone-Bizzozero, N.I. (1998) Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biological Psychiatry 43, 239-243.
242. Thune, J.J., Uylings, H.B.M. & Pakkenberg, B. (2001). No deficit in total number of neurons in the prefrontal cortex in schizophrenics. Journal of Psychiatric Research 35, 15-21.
243. Tkachev, D., Mimmack, M.L., Ryan, M.M. et al. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805.
244. Torrey, E.F., Barci, B.M., Webster, M.J. et al. (2005) Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biological Psychiatry 57, 252-260.
245. Uranova, N.A., Orlovskaya, D.D., Vikhreva, O. et al. (2001) Electron microscopy of oligodendroglia in severe mental illness. Brain Research Bulletin 55, 597-610.
246. Uranova, N.A., Vostrikov, V.M., Orlovskaya, D.D. & Rachmanova, V.I. (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research 67, 269-275.
247. Van Snellenberg, J.X., Torres, I.J. & Thornton, A.E. (2006) Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology 20, 497-510.
248. Vawter, M.P., Crook, J.M., Hyde, T.M. et al. (2002). Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: A preliminary study. Schizophrenia Research 58, 11-20.
249. Velakoulis, D., Panetelis, C., McGorry, P.D. et al. (1999) Hippocampal volume in fi rst-episode psychosis and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Archives of General Psychiatry 56, 133-141.
250. Volk, D.W., Austin, M.C., Pierri, J.N. et al. (2000) Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in subjects with schizophrenia. Archives of General Psychiatry 57, 237-245.
251. Volk, D.W., Austin, M.C., Pierri, J.N. et al. (2001) GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: Decreased expression in a subset of neurons. American Journal of Psychiatry 158, 256-265.
252. Volk, D.W., Pierri, J.N., Fritschy, J.M. et al. (2002) Reciprocal alterations in pre-and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cerebral Cortex 12, 1063-1070.
253. Vostrikov, V.M., Uranova, N.A. & Orlovskaya, D.D. (2007) Defi cit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophrenia Research 94, 273-280.
254. Walker, M.A., Highley, J.R., Esiri, M.M. et al. (2002) Estimated neuronal populations and volumes of the hippocampus and its subfi elds in schizophrenia. American Journal of Psychiatry 159, 821-828.
255. Weickert, C. & Weinberger, D.R. (1998) A candidate molecular approach to defi ning the developmental pathology in schizophrenia. Schizophrenia Bulletin 24, 303-316.
256. Weinberger, D.R. (1999) Cell biology of the hippocampal formation in schizophrenia. Biological Psychiatry 45, 395-402.
257. Wisniewski, H.M., Constantinidis, J., Wegiel, J. et al. (1994) Neurofi brillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Disease and Associated Disorders 8, 211-227.
258. Woo, T.U., Miller, J.L. & Lewis, D.A. (1997a) Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. American Journal of Psychiatry 154, 1013-1015.
259. Woo, T.-U., Pucak, M.L., Kye, C.H. et al. (1997b) Peripubertal refi nement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience 80, 1149-1158.
260. Woo, T.-U., Whitehead, R.E., Melchitzky, D.S. & Lewis, D.A. (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proceedings of the National Academy of Sciences USA 95, 5341-5346.
261. Woo, T.-U., Walsh, J.P. & Benes, F.M. (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Archives of General Psychiatry 61, 649-657.
262. Wright, I.C., Rabe-Hesketh, S., Woodruff, P.W.R., David, A.S. et al. (2000) Meta-analysis of regional brain volumes in schizophrenia, American Journal of Psychiatry 157, 16-25.
263. Young, K.A., Manaye, K.F., Liang, C.-L. et al. (2000) Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biological Psychiatry 47, 944-953.
264. Young, K.A., Holcomb, L.A., Yazdani, U. et al. (2004) Elevated neuron number in the limbic thalamus in major depression. American Journal of Psychiatry 161, 1270-1277.
265. Zaidel, D.W., Esiri, M.M. & Harrison, P.J. (1997a) The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychological Medicine 27, 703-713.